[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349553-105":59,"doc-detail-349553-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","histone-acetyltransferase-hbo1-in-cancer-biology-essential-mechanisms-and-implications-for-targeted-therapeutics","Histone acetyltransferase HBO1 in cancer biology - Essential mechanisms and implications for targeted therapeutics","","The histone acetyltransferase complex HBO1 (KAT7) functions as an oncogenic regulator across multiple cancers, driving cell proliferation and migration and contributing to transcriptional activation and genomic stability. HBO1 forms assemblies with multiple cofactors to acetylate histones H3 and H4, localizes to active transcriptional sites, and participates in gene regulation, DNA repair, and replication. Although many cancer mutations are missense, their impacts remain incompletely defined. Silencing HBO1 restores normal proliferation and gene expression. The review also highlights WM-3835 as an HBO1 inhibitor that disrupts H3K14 acetylation and suppresses tumor growth, outlining how HBO1 supports apoptosis resistance, DNA damage response, and cell cycle control, and how this knowledge may inform epigenetic targeted therapies for HBO1-driven malignancies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/histone-acetyltransferase-hbo1-in-cancer-biology-essential-mechanisms-and-implications-for-targeted-therapeutics/349553/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/histone-acetyltransferase-hbo1-in-cancer-biology-essential-mechanisms-and-implications-for-targeted-therapeutics/349553.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does the HBO1 (KAT7) complex play in cancer biology?","Question",{"text":113,"@type":114},"HBO1 acts as an oncogenic regulator that promotes cancer cell proliferation and migration. It acetylates histones to support transcriptional activation, genomic stability, and broader gene-regulatory functions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does HBO1 form functional complexes and what substrates does it target?",{"text":118,"@type":114},"HBO1 assembles with cofactors such as MEAF6, JADE(1/2/3), ING(ING4/5), and BRPF1/2/3. These interactions enable HBO1 to acetylate histones H3 and H4, especially at H3K14, shaping transcription and genome stability.",{"name":120,"@type":111,"acceptedAnswer":121},"Are there targeted therapies against HBO1 currently, and what is WM-3835?",{"text":122,"@type":114},"No HBO1-targeted therapies are approved for clinical use, but the inhibitor WM-3835 disrupts H3K14 acetylation. In multiple cancers, this reduces tumor growth, supporting HBO1 as a therapeutic target.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349553,1790189314,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Biochim Biophys Acta Rev Cancer. Author manuscript; available in PMC 2026 August 20. |\n| --- | --- |\n\nPublished in final edited form as:  \nBiochim Biophys Acta Rev Cancer. 2026 April ; 1881(2): 189533. doi:10.1016/j.bbcan.2026.189533 .  \nHistone acetyltransferase HBO1 in cancer biology: Essential mechanisms and implications for targeted therapeutics  \n*  \nAlissa D. Marchione, Katie L. Kathrein  \nDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, United States of America  \nAbstract  \nThe histone acetyltransferase complex HBO1 (KAT7) is an oncogenic regulator across multiple cancers, promoting cell proliferation and migration. Though clinically important, no targeted therapies address HBO1 dysregulation. HBO1 forms complexes with MEAF6, JADE(1/2/3), ING(ING4/5), and BRPF1/2/3 to acetylate histones H3 and H4, especially at H3K14, promoting transcriptional activation and genomic stability. It colocalizes with active transcriptional sites and participates in gene regulation, DNA repair and replication. Most HBO1-associated cancer mutations are missense, though their effects remain unclear. Silencing HBO1 restores normal proliferation and gene expression, underscoring its oncogenic role. HBO1 activity supports cancer pathways, including apoptosis resistance, DNA damage response, and cell cycle regulation.  \nThe HBO1 inhibitor WM-3835 disrupts H3K14 acetylation, reducing tumor growth in several cancers. This review provides insights into the function of HBO1 in cancer, especially in histone acetylation, ubiquitination, stem cell maintenance, and pro-and anti-oncogenic signaling. Understanding the roles of HBO1 may guide new epigenetic therapies for HBO1-driven malignancies.  \nKeywords  \nHBO1/KAT7; Histone acetyltransferase; HBO1 complex; Oncogenesis; Targeted therapy  \n1. Introduction  \nCancer remains a leading cause of mortality worldwide, with millions of deaths annually attributed to uncontrolled cellular growth, proliferation, and aggressive malignancy [1,2] . The molecular complexity of cancer involves distinct genetic and epigenetic alterations unique to each cancer type and even individual tumors [3–5]. Among epigenetic regulators, histone-modifying enzymes that create various post-translational modifications (PTMs) on  \nThis is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \n*[Corresponding author. klk@sc.edu](Corresponding author. klk@sc.edu) (K.L. Kathrein) .  \nAuthor Contribution  \nAM and KLK were responsible for conceptualization, data curation, manuscript preparation, review, and editing. Both authors read and approved the final version of the manuscript submitted for publication.  \nDeclaration of competing interest  \nThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nMarchione and Kathrein Page 2  \nhistones have attracted growing attention as critical determinants of chromatin structure and gene expression, positioning them as promising therapeutic targets [5–7] .  \nHistone acetylation, facilitated by histone acetyltransferases (HATs), regulates chromatin accessibility and affects various cellular processes, including transcription, DNA replication, and repair. Dysregulation of HAT activity is linked to cancer development, as abnormal acetylation patterns can lead to increased oncogene expression and tumor growth [7,8] .  \nHBO1 (Histone Acetyltransferase Binding to ORC1, also known as KAT7) is a MYST family HAT that acetylates histone H3 and H4 at specific lysine residues, playing a crucial role in chromatin remodeling and genome stability [9–11] . HBO1 forms a complex with cofactor","cbCaimWW7fHQV4JQ","https://ap.wps.com/l/cbCaimWW7fHQV4JQ","pdf",1122975,27,"English","# Introduction\n# Structure and function of HBO1 and the HBO1 complex\n## HBO1 structure\n## HBO1 and the HBO1 complex: multifunctional acetyltransferase","[{\"question\":\"What role does the HBO1 (KAT7) complex play in cancer biology?\",\"answer\":\"HBO1 acts as an oncogenic regulator that promotes cancer cell proliferation and migration. It acetylates histones to support transcriptional activation, genomic stability, and broader gene-regulatory functions.\"},{\"question\":\"How does HBO1 form functional complexes and what substrates does it target?\",\"answer\":\"HBO1 assembles with cofactors such as MEAF6, JADE(1/2/3), ING(ING4/5), and BRPF1/2/3. These interactions enable HBO1 to acetylate histones H3 and H4, especially at H3K14, shaping transcription and genome stability.\"},{\"question\":\"Are there targeted therapies against HBO1 currently, and what is WM-3835?\",\"answer\":\"No HBO1-targeted therapies are approved for clinical use, but the inhibitor WM-3835 disrupts H3K14 acetylation. In multiple cancers, this reduces tumor growth, supporting HBO1 as a therapeutic target.\"}]","Histone acetyltransferase HBO1 in cancer biology - Essential mechanisms and implications for targeted therapeutics | PDF",1790084301,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/466048c1b0c9c521dc9959d53c3711e3.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dc70eb022465a9f052c75d0637be269.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aab3d05ec1f24e84583f07483b56d88.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e627f2335fc857ca2adc2d2b61e0caec.webp",980,1268]